Cryo-ablation for septal tachycardia substrates in pediatric patients Mid-term results by Miyazaki, Aya et al.
C
S
M
A
C
C
f
o
s
(
t
e
(
m
l
p
p
a
l
m
p
c
l
m
b
s
S
T
2
Journal of the American College of Cardiology Vol. 45, No. 4, 2005
© 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00
Pryo-Ablation for Septal Tachycardia
ubstrates in Pediatric Patients
id-Term Results
ya Miyazaki, MD, Andrew D. Blaufox, MD, David L. Fairbrother, MD, J. Philip Saul, MD
harleston, South Carolina
OBJECTIVES The aim of this study was to evaluate the efficacy and safety of catheter-based cryo-therapy
for septal tachycardia substrates in pediatric patients.
BACKGROUND Cryo-therapy may be particularly useful for ablation of septal tachycardias, including
atrioventricular nodal re-entry tachycardia (AVNRT), atrioventricular reciprocating tachy-
cardia (AVRT), and ventricular tachycardia (VT) originating high in the conduction system.
METHODS Thirty-one pediatric patients (median  13.7 years, range 5.3 to 19.6 years) with septal
tachycardia substrates underwent cryo-ablation (CA). Twenty-two had AVNRT, 8 AVRT,
and 1 VT. Applications were considered cryo-maps (CMs) if the temperature set-point was
35°C or the application time was 120 s. Other lesions were considered CAs.
RESULTS A total of 242 CMs (4 per patient, range 0 to 40 CMs) and 89 CAs (2 per patient, range 1
to 8 CMs) were performed, for a total cryo-therapy time of 689 s/patient (range 158 to 3,300
s). Procedural success with cryo-therapy was achieved in 27 of 31 patients (87.1%), including
two procedures with a His potential at the CA location and three performed in tachycardia.
The success rate for AVNRT was higher than for AVRT (95.5% vs. 62.5%, p  0.05). For
AVRT, a sustained effect on accessory pathway conduction occurred 3.3  4.9 s after
reaching 25°C, whereas for those sites at which the effect was transient, the effect took 24.8
 25.5 s (p  0.07). Transient atrioventricular (AV) block occurred during eight cryo-
applications (1 CA, 7 CMs) with immediate return of normal AV conduction upon cessation
of application. There were no other complications.
CONCLUSIONS Cryo-therapy was used to effectively and safely ablate septal tachycardias in this group of 31
pediatric patients. Cryo-therapy may be more effective for AVNRT than septal
AVRT. (J Am Coll Cardiol 2005;45:581–8) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.10.051Cardiology Foundation
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Iatheter-based cryo-therapy has been introduced recently
or ablation of a variety of cardiac arrhythmias (1–8), but
nly limited reports exist in children (9). Cryo-therapy has
everal potential advantages over radiofrequency ablation
RFA), which include: 1) reversible cryo-mapping before
he production of a permanent lesion (1,10,11); 2) adher-
nce of the catheter tip to the endocardium upon freezing
2); 3) a well-defined edge of the cryo-lesion (10); 4)
inimal effects on adjacent coronary arteries (1); and 5) a
ower incidence of thrombus (12). The first four of these are
articularly relevant to small children because of the close
roximity of a variety of critical cardiac structures to the
blation target and the reported potential for radiofrequency
esion growth in immature myocardium (13). In fact, the
ost common major complication during RFA in pediatric
atients is atrioventricular (AV) block (14–16). Acute
oronary artery injury has also been reported in a variety of
ocations in children (17,18), including during slow pathway
odification (17).
This report addresses the efficacy and safety of catheter-
ased cryo-therapy in pediatric patients for ablation of
eptal tachycardias, including atrioventricular nodal re-entry
From The Children’s Heart Program of South Carolina-Medical University of
outh Carolina, Charleston, South Carolina. Dr. Saul is a consultant for CryoCath
echnologies Inc., Montreal, Quebec, Canada.n
Manuscript received August 30, 2004; revised manuscript received October 12,
004, accepted October 26, 2004.achycardia (AVNRT), atrioventricular reciprocating tachy-
ardia (AVRT) caused by a septal accessory pathway, and
entricular tachycardia (VT) originating high in the con-
uction system.
ETHODS
he pediatric ablation registry at the Medical University of
outh Carolina was searched for all patients who had
ndergone catheter-based cryo-ablation (CA) for tachycar-
ias with septal substrates during the period fromMay 2003
ntil July 2004. Only patients with structurally normal
earts under 20 years of age were included in the analysis.
lectrophysiologic study. Informed written consent was
btained before each procedure. All anti-arrhythmic drugs
ere discontinued for at least five half-lives. Under either
eneral anesthesia or conscious sedation, all patients under-
ent an electrophysiologic study using standard pacing and
apping techniques to determine the mechanism of the
achycardia and the location of the ablation target. Patients
ere administered an initial heparin bolus of 100 IU/kg up
o 5,000 IU. Activated clotting times were checked every 30
in, and additional heparin boluses were given to keep the
ctivated clotting time 200 s (right) or 250 s (left).
soproterenol was administered when the tachycardia was
ot inducible at baseline.
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Cryo-Ablation for Septal Tachycardias in Children February 15, 2005:581–8ryo-therapy. Once a target had been established, cryo-
apping and CA were undertaken using a microprocessor-
ased electromechanical refrigeration console controlling a
-F, 4-mm or 6-mm tipped ablation catheter (CryoCon-
ole, Freezor, Freezor Xtra, CryoCath Technologies Inc.,
ontreal, Canada). For AVNRT, both anatomical and
lectrogram criteria were used to choose initial application
ites (19). For AVRT, sites for cryo-applications were
etermined on the basis of previously reported standard
apping criteria (20). For the patient with VT, the site of
arliest ventricular activation was used as an ablation target.
ryo-therapy was performed in sinus rhythm, with atrial or
entricular pacing, or in slow junctional rhythm. However,
n contrast to RFA, cryo-therapy was also used both during
ctive tachycardia (AVNRT or AVRT) and in the presence
f isoproterenol, because junctional acceleration is not
enerally present during cryo-therapy, and because catheter
dherence during cryo-therapy allows for catheter stability
uring tachycardia or isoproterenol infusion. Cryo-therapy
as initiated with either a preset minimal temperature of
35°C for up to 1 min, or a preset temperature of 70°C
or up to 8 min. For the purposes of this study, a “cryo-map”
CM) was defined as any application with a set-point of
35°C or a colder application of 120 s duration. A CA
as defined as an application with a set-point of70°C that
as 120 s. Each CM or CA was considered a separate
ryo-application. The number of “cryo-sites” was defined as
he number of anatomically separate locations where either
CM or CA was delivered. If an application at a single site
as initiated as a CM but then extended to a CA, it was
ounted as two cryo-applications, but one cryo-site. “Ap-
lication time” was defined as the time of each CA or CM.
Cryo-therapy time” was defined as the time from 25°C
ntil the termination of cryo-therapy at each cryo-site.
The decision to proceed from CM to CA was made using
ne or more of the following criteria: 1) AVNRT termina-
ion in the slow pathway; 2) modification or elimination of
he slow pathway during atrial extra-stimulus testing; 3)
ccessory pathway block during sinus rhythm, ventricular
acing, or AVRT; and 4) for this VT case, a site of early
entricular activation not associated with AV block. For any
M or CA, the application was immediately discontinued
or any degree of AV block.
ryo-site success. Each cryo-site was classified by the
Abbreviations and Acronyms
AV  atrioventricular
AVNRT  atrioventricular nodal re-entry tachycardia
AVRT  atrioventricular reciprocating tachycardia
CA  cryo-ablation
CM  cryo-map
RAS  right anteroseptal
RFA  radiofrequency ablation
VT  ventricular tachycardiautcome at that location, as success, transient success, failure, or post-success (additional application). A cryo-site
as considered successful if it resulted in elimination of the
low pathway, the accessory pathway, or the disappearance
f VT. A cryo-site was considered a transient success if
here was recurrence of the arrhythmia or its substrate
ithin 30 min of cryo-therapy termination. A cryo-site was
onsidered a failure if it had no effect on the substrate. A
ryo-site was considered post-success if it was performed
ery near the location of a previously successful cryo-site.
rocedural success. Procedural success was defined using
FA standards, including a minimum of 30 min of post-
blation testing. No inducible tachycardia was mandatory
or any substrate. For AVNRT, a procedure was deemed
uccessful if there was elimination of the slow pathway or
ot more than a single echo beat. For AVRT, loss of
ccessory pathway conduction was also required. If isopro-
erenol was required for the assessment of slow pathway or
ccessory pathway conduction or for the induction of
achycardia before ablation, the use of isoproterenol was
equired during post-ablation testing to deem the procedure
success. If cryo-therapy was considered a failure, a switch
as generally made to RFA; however, there was no preset
rotocol for making this determination. The investigators
ended to switch more readily when the results of the
ryo-therapy indicated that the pathway location was one
here there was a lower risk of AV block.
tatistical analysis. Values are shown as median and range
nless otherwise specified. Comparisons were made with
he two-tailed unpaired Student t test or by Fisher exact
est, whenever appropriate. A p value 0.05 was considered
tatistically significant.
ESULTS
atients. Thirty-three pediatric patients with septal tachy-
ardia substrates underwent catheter-based cryo-therapy.
wo patients with AVNRT and congenital heart disease
ere excluded because of variation in AV node anatomy.
hus, 31 patients (19 male; age 13.7 years, range 5.3 to 19.6
ears; weight 51.4 kg, range 19.7 to 130.2 kg) are included
n this study (Table 1). Twenty-two patients had AVNRT,
AVRT, and 1 VT. Among patients with AVRT,
ccessory pathway locations were as follows: five right
nteroseptal (RAS), one right mid-septal, and two right
osteroseptal.
The RFA had been performed previously in four patients.
wo of these patients had recurred after a previous RFA
ttempt (1 AVNRT, 1 AVRT), and one had undergone
uccessful RFA of permanent junctional reciprocating
achycardia but subsequently developed AVNRT. The one
ith VT had failed RFA twice at another institution.
nother two patients (1 AVNRT, 1 AVRT with RAS
athway) had undergone an electrophysiologic study at
nother institution, but did not undergo RFA because of
nstable fast pathway conduction or a perceived high risk
or AV block.
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February 15, 2005:581–8 Cryo-Ablation for Septal Tachycardias in Childrenryo-sites and cryo-applications. In all but two patients,
he 4-mm tipped ablation catheter was used (Table 1), with
he 6-mm tipped catheter also used in the remaining
atients. The ablation site was accessed via the inferior vena
ava in 29 patients, the superior vena cava in 1 patient, and
he aorta in the patient with VT (Table 1).
A total of 290 cryo-sites were analyzed (median 5.0 per
atient), with a wide range in the number of sites (1 to 42)
Table 1). A His signal was seen on the cryo-catheter just
efore and after cryo-therapy in four patients at 15 sites
median 3.5 sites, range 1 to 7 sites). The rhythm at the
eginning of cryo-therapy was sinus at 194 sites, tachycardia
t 45 sites, atrial or ventricular pacing at 39 sites, and slow
unctional rhythm at 12 sites. Cryo-therapy was performed
uring isoproterenol infusion at 137 sites.
Two hundred forty-two CMs (median 4 per patient,
ange 0 to 40 CMs) and 89 CAs (median 2 per patient,
ange 1 to 8 CMs) were performed. There was a wide range
n the total cryo-therapy time for each patient (range 158 to
,300 s, median 689 s).
uccess. Procedural success was achieved in 27 of 31
atients (AVNRT 21 of 22, AVRT 5 of 8, VT 1 of 1). For
able 1. Patient Characteristics, Number of Cryo-Sites, and Rhy
Patient
#
Age
(yrs)
Body Weight
(kg) Diagnosis Approach
1 9.6 35.6 TYP IVC
2 12.8 55.3 TYP IVC
3 13.7 59.7 TYP, ATYP IVC
4 15.1 130.2 TYP IVC
5 18.3 82.5 ATYP IVC
6 17.5 66.2 TYP, ATYP IVC
7 17.4 63.0 TYP IVC
8 12.3 41.8 TYP IVC
9 5.3 19.7 ATYP IVC
10 13.5 78.4 TYP, ATYP IVC
11 12.9 51.4 TYP IVC
12 19.6 64.8 TYP IVC
13 13.4 60.7 TYP IVC
14 17.9 68.3 TYP IVC
15 9.56 47.3 TYP IVC
16 17.56 65.8 TYP IVC
17 13.67 46 TYP IVC
18 15.77 56.9 TYP, ATYP IVC
19 8.59 27.9 TYP IVC
20 17.22 66.1 TYP IVC
21 14.60 55.6 TYP IVC
22 16.15 59.1 TYP IVC
23 12.9 46.5 RAS IVC
24 7.3 27.1 RAS, WPW SVC
25 11.2 51.4 RAS IVC
26 15.4 51.2 RAS, WPW IVC
27 14.1 44.0 RMS, WPW IVC
28 9.53 36.6 RPS, WPW IVC
29 8.02 24.9 RPS, WPW IVC
30 10.24 27.2 RAS, WPW IVC
31 13.8 43.0 VT Ao
Total
o  aorta; Iso  isoproterenol; IVC  inferior vena cava; RAS  right anterosepta
achycardia; TYP/ATYP  typical/atypical atrioventricular nodal reentry tachycardiahe 21 patients with AVNRT procedural success, slow tathway conduction was completely eliminated in 9 patients
nd modified in the remaining 12 patients, with no echo
eats in 8 patients and one echo beat in 4 patients . The 12
atients with a modified slow pathway were classified as
aving undergone a successful procedure, because only
ryo-site success was defined as complete elimination of the
low pathway, whereas procedural success was defined as
aving no more than a single AV nodal echo. The three
atients who failed cryo-therapy were successfully ablated
ith radiofrequency energy. One patient with a RAS
athway did not go on to RFA because accessory pathway
onduction was intermittent after cryo-therapy led to tran-
ient AV block at the same cryo-site. Cryo-therapy was
erformed during tachycardia at 45 cryo-sites, resulting in
hree permanent successes and five transient successes. Of
he 137 cryo-sites where an application was made during
soproterenol infusion, permanent success was achieved at 4
ites and transient success was achieved at 14 sites.
For AVRT, where loss of pathway conduction could be
mmediately assessed, a sustained effect on accessory path-
ay conduction occurred 3.3  4.9 s after reaching
25°C, whereas for those sites at which the effect was
During Cryo-Therapy
eter
Cryo-sites
(n)
Cryo in His
(n)
Cryo in Tach
(n)
Cryo on Iso
(n)
tip 2 0 1 1
tip 11 0 11 0
tip 23 0 13 0
tip 22 0 1 0
tip 5 0 1 5
tip 3 0 0 3
tip 26 2 3 22
tip 6 0 0 0
tip 5 0 0 0
tip 18 0 3 16
tip 21 0 0 21
tip 15 0 0 15
tip 12 0 4 6
tip 5 0 1 0
tip 2 0 0 2
tip 42 5 0 32
tip 5 0 0 1
tip 10 0 0 0
tip 7 0 2 0
tip 6 0 0 0
tip 12 0 0 10
tip 2 0 0 0
tip 4 0 4 0
tip 3 0 0 3
tip 1 1 1 0
tip 2 0 0 0
tip 4 0 0 0
tip 1 0 0 0
tip 1 0 0 0
tip 2 0 0 0
tip 12 7 0 0
290 15 45 137
S  right midseptal; RPS  right posteroseptal; SVC  superior vena cava; Tach 
W  Wolff-Parkinson-White syndrome.thm
Cath
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
4-mm
6-mm
4-mm
4-mm
4-mm
4-mm
6-mm
4-mm
4-mm
4-mm
4-mmransient, the effect took 24.8  25.5 s (p  0.07) (Fig. 1).
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Cryo-Ablation for Septal Tachycardias in Children February 15, 2005:581–8Successful lesions, which resulted in complete substrate
limination without return of substrate conduction before
he end of the procedure, occurred at 15 sites. These sites
ere the nine slow pathways, five accessory pathways, and
he VT that were completely eliminated as stated previously.
ransient success, where complete elimination of the sub-
trate during an application was only temporary, was seen at
5 sites. Lesion failure, where there was no elimination of
ubstrate during the application, was seen at 229 sites.
ost-success applications were performed at 11 sites. Two
uccesses were achieved in the presence of a large His
otential on the ablation catheter (Figs. 2 and 3).
omplications. Some form of transient AV block was seen
uring six applications and soon after termination of two
pplications (7 of 242 CMs vs. 1 of 89 CAs, p  NS). All
ight episodes were during sinus rhythm, of which six
ccurred during isoproterenol infusion. An AV block oc-
urred in 6 of 137 sites without isoproterenol and 2 of 153
ites with isoproterenol (p  NS). Fast pathway block,
anifest by atriohisian prolongation, was seen in five
atients, Wenckebach block in two patients, and high-grade
econd-degree AV block in one patient (Table 2). A His
otential was present on the ablation catheter at the begin-
ing of one application that resulted in first-degree AV
lock. Transient AV block occurred a median of 52.5 s
range 15 to 189 s) after reaching 25°C at a median
inimum temperature of 73.5°C (31°C to 81°C). All
pplications were terminated immediately upon recognition
f AV block, and in all cases AV node function recovered
uickly. Junctional acceleration was not observed in any
atient during cryo-therapy. Mechanical catheter manipu-
ation caused transient fast pathway block in two patients
ith AVNRT, not associated with cryo-therapy. There
ere no other complications.
ecurrence. During follow up of 8.2 months (range 0.8 to
4.4 months), 3 of 27 patients (11.1%) had a recurrence, all
ithin four weeks of the procedure. One patient had
VNRT (Patient #12), and two had AVRT (Patients #24
igure 1. Time of success after reaching 25°C. During atrioventricular
eciprocating tachycardia ablation, accessory pathway (AP) block after
eaching 25°C occurred in 3.3  4.9 s in permanent success in
omparison to 24.8  25.5 s in transient success.nd #26). Before the ablation, Patient #24 had pre- txcitation and frequent episodes of AVRT. During the
blation procedure, the accessory pathway had intermittent
onduction, which was eliminated with catheter manipula-
ion during mapping. Retrograde pathway conduction was
hen cryo-ablated using an approach from the superior vena
ava to the ventricular side of the AV annulus, owing to a
arge His potential at the site of earliest activation on the
trial side. Pre-excitation was not seen during the procedure
ut recurred within two weeks. However, the patient has
ot had AVRT recurrence, suggesting that retrograde con-
uction was successfully ablated. If this patient were
ounted as a clinical success, the recurrence rate would be
educed to 9.0%. No variable was found to be associated
ith recurrence. Both Patients #12 and #26 subsequently
ent on to a successful RFA procedure.
VNRT versus AVRT. Table 3 compares demographic
ariables and results for patients with AVNRT and AVRT.
atients with AVNRT were statistically older and heavier
han patients with AVRT. The number of cryo-sites, CAs,
Ms, total cryo-applications, and total cryo-therapy time
ere all greater for AVNRT than AVRT patients. The
uccess rate was higher for AVNRT than AVRT (95.5% vs.
2.5%, p  0.05); however, the recurrence rate was not
tatistically different (4.8% vs. 40.0%, p  NS).
ISCUSSION
his study demonstrates several important points about
ryo-ablation of septal tachycardia substrates in pediatric
atients. First and foremost, despite patient size as small as
0 kg, cryo-ablation was performed safely around the AV
onduction system in this group of pediatric patients, even
n the presence of a His potential. Second, cryo-ablation is
n effective alternative to RFA for most septal substrates.
hird, in contrast to RFA, cryo-therapy was safely and
ffectively delivered near the AV conduction system both
uring tachycardia and during isoproterenol infusion. Fi-
ally, cryo-therapy may be the only technique where avoid-
nce of AV conduction damage can be nearly ensured
uring ablation attempts of tachycardia substrates such as
T originating high in the conduction system and some
ccessory pathways.
efinition of CM versus CA. Before discussing the im-
lications of this study, it is important to understand why
he definitions of CM and CA were modified compared
ith previous studies. In this study, a CM was defined as an
pplication at any temperature with a duration of 120 s,
hereas in previous studies, a CM was defined as a
ryo-application with a preset minimum temperature be-
ween 15°C and 40°C (2–4,6,10,11,12). Our definition
as based both on these previous clinical reports and
revious animal studies (1,3,10,11), suggesting that perma-
ent electrophysiologic effects require longer application
imes at lower temperatures. Dubuc et al. (11) reported that
ransient high-degree AV block was produced in dogs at
emperatures near 40°C. However, permanent AV block
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February 15, 2005:581–8 Cryo-Ablation for Septal Tachycardias in Childrennly occurred with temperatures below 50°C applied for
ore than 5 min. Because the goal of a CA is to produce
ermanent loss of tissue function, it did not make sense to
efine all applications at lower temperatures or that were
iscontinued early as CAs. Thus, 120 s at any temperature
as chosen as the cutoff.
fficacy. Acute success in this study was achieved in 87.1%
f all patients, including 95.5% of those with AVNRT and
2.5% of those with AVRT. These results are not as
atisfactory as the results reported in recent large series of
FA for similar substrates in pediatric patients (AVNRT
9%, septal AVRT 90%) (21). However, a number of
actors must be taken into account. The present report
onstitutes the initial experience with a new technology
igure 2. Successful cryo-ablation (CA) with His potential in tachycardia
rom the ablation catheter is caused by the formation of the ice ball and
uring tachycardia with the His potential seen in the ablation catheter. (
otential is seen in ablation catheter. (C) Electrocardiogram shows the
erminated with ventriculoatrial block just 0.6 s before reaching 25°C an22–25). Two initial reports on the use of RFA for su- hraventricular tachycardia substrates in small pediatric
roups revealed acute success rates of 68% and 82% (22,23).
urther, Danford et al. (25) showed that the learning curve
or RFA in the Pediatric Ablation Registry was dependent
pon the tachycardia mechanism and substrate location, and
hat the steady state for efficacy was not reached until
pproximately 50 previous procedures. Because the physi-
ians in the present study have the advantage of previous
xperience with RFA, one might not expect such a long
earning curve, but a number of differences in the techniques
uggest that some learning curve will be present. For
nstance, the current generation of cryo-catheters is not
early as flexible as the current generation of RFA catheters.
he lack of familiarity with the cryo-ablation catheter’s
ht anteroseptal (RAS) pathway (Patient #25). The large increase in noise
dhesion. (A) Electrocardiogram at the initiation of cryo-mapping (CM)
lectrocardiogram at the termination of CA shows sinus rhythm and His
nation of tachycardia during CM. The supraventricular tachycardia was
.4 s from the initiation of CM. ABL  ablation; CS  coronary sinus.of rig
cryo-a
B) E
termiandling characteristics could have translated into a lower
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Cryo-Ablation for Septal Tachycardias in Children February 15, 2005:581–8rocedural success rate (3). In addition, the time to effect for
successful cryo-application in the present study was much
onger than that for RFA (26), making it difficult to judge
hen to terminate an application. The notion of a learning
urve suggests that success rates will increase over time.
ortunately, this study suggest that RFA can still be safely
pplied after failure of cryo-therapy, indicating that cryo-
herapy can be used as a safe initial approach for septal
ubstrates, reducing the number of patients exposed to
FA.
In the present study, cryo-therapy was more effective for
VNRT than AVRT with septal accessory pathway. The
VNRT success rate in this report is similar to that using
ryo-therapy for AVNRT in adults (94%, 91%) (2,3).
lthough the success for AVRT in this small group of
ubjects was not as good as early reports for cryo-therapy in
dults with septal pathways (100%) (4,5), it is comparable to
recent study involving AVRT in all locations (69%) (3). A
umber of factors may have contributed to these results.
ecause cryo-lesions are more delineated (9) and smaller
igure 3. Successful cryo-ablation (CA) with His potential in ventricu
ryo-mapping (CM). The His potential is clearly seen on the ablation cat
f the cryo-ablation catheter being very near the His bundle. The cathete
pproach through the aortic valve. ABL  ablation; HBE  His bundle
able 2. Applications With Transient AV Block
Patient # AVB His Rhythm Isoproterenol
3 I  S 
5 IIa*  S 
5 IIb  S 
6 IIa*  S 
7 I  S 
7 I  S 
11 I  S 
30 I  S 
AV block occurred 10 s after termination of cryo-therapy.
AV  atrioventricular; AVB  atrioventricular block; Min Temp  minimum tempera
Ib  second-degree AV block type 2; S  sinus rhythm.han radiofrequency lesions (12), cryo-ablation may require
ore precise positioning, particularly for the relatively
iscrete accessory pathways. The learning curve for AVRT
ay have been less steep because of early abandonment of
ryo-therapy in favor of radiofrequency energy at locations
ith electrographic characteristics considered adequate for
he well-known effects of radiofrequency therapy. Also a
ossibility, though difficult to quantify, safe application of
ryo-therapy in a particular location may have provided
ome level of confidence for applying radiofrequency energy
n the same location, again lowering the threshold for
hanging therapies earlier in the procedure.
ime to accessory pathway block. After reaching 25°C,
ccessory pathway block occurred earlier when the delivered
ryo-therapy was permanently successful than when it was
ransiently successful (Fig. 3). This finding did not reach
tatistical significance, needing to be substantiated in a
arger group of pediatric patients, but it is in agreement with
revious reports. Gaita et al. (4) reported that accessory
athway conduction block occurred during cryo-mapping a
chycardia (Patient #31). (A) Electrocardiogram shows the initiation of
(B) Fluoroscopic images in the antero-posterior view shows the position
st under the aortic valve along the left ventricular septum via retrograde
ogram; HRA  high right atrium.
-Therapy Time
(s)
Time <35°C
(s)
Min Temp
(°C)
Time to
Recovery
(s)
79 47 81 3
189 157 73 3
78 8 74 35
52 35 38 193
51 15 77 5
20  31 5
15 14 63 13
53 44 77 20lar ta
heter.Cryoture; I AVB  first-degree AV block; IIa AVB  second-degree AV block type 1;
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chieved, and that sudden conduction block over the acces-
ory pathway during CM was predictive of permanent
uccess. A rapid loss of electrical conduction during higher
emperature mapping should indicate that the target is well
ithin the cooling zone and that with lower temperature
nd more time cell death will occur. Alternatively, later loss
f conduction suggests the target is more distant and even
ower temperatures at the electrode may not cause cell death
t the target. This concept is similar to that with heating for
FA, but the time to effect for RFA is compressed
ompared with cryo-ablation (26).
afety. In this small series of patients, there were no
nstances of permanent AV block despite the large number
f septal applications and seven instances of transient
rst-degree and second-degree AV block. Both the CM and
A modes allowed for reversible loss of tissue function,
imilar to that previously reported in animals and humans
uring CM (1,3,10,11). These transient effects occurred for
oth the normal AV conduction fibers and the targeted
achycardia substrate. Despite the fact that AV block was
bserved in this study at temperatures below 50°C in five
f the seven cases (Table 2), all instances of block fully
ecovered after termination of cryo-therapy, probably be-
ause cryo-therapy was immediately terminated at the first
ign of AV block. Friedman et al. (3) also reported 12
nstances of transient AV block, 11 of which occurred
uring cryo-ablation modes, and all of them resolved
ompletely. Because the leading edge of the ice ball during
ryo-therapy is by definition near 0°C and warmer than the
emperature measured at the catheter tip, it is likely that
iscontinuation of cryo-therapy at the first signs of an
lectrophysiologic effect will reverse that effect. Conversely,
ecause AV block occurred after the temperature had been
et to 70°C, careful attention, including intermittent
rogrammed stimulation, should be used to evaluate AV
onduction in both the mapping and ablation modes,
hether or not isoproterenol is being used. Another poten-
ial safety feature of cryo-therapy is catheter stability at the
oint of tissue freeze. This lack of tip movement should
oth improve success when the catheter is in the correct
Table 3. AVNRT Versus AVRT
All Pati
n 31
Age (yrs) 13.4 
Body weight (kg) 53.4 
Cryo-sites (#/pt) 9.4 
CM (#/pt) 7.8 
CA (#/pt) 2.9 
Total applications (CA  CM) (#/pt) 10.7 
Total cryo-therapy time (s/pt) 1,096 
Procedural successes, n (%) 27 (87
Recurrence, n (%) 3 (11
AVNRT  atrioventricular nodal reentry tachycardia; AVRT
CM  cryo-map; pt  patient.lace (2) and prevent lesion spread to undesirable locations phrough the sliding movement seen with RFA. Catheter
tability is particularly helpful when programmed stimula-
ion is performed, isoproterenol is administered during
blation, or when tachycardia stops during the application.
As reported previously (2), junctional acceleration did not
ccur in the present study, avoiding the masking of AV
ode conduction by junctional acceleration seen during
FA, and allowing for a more thorough assessment of fast
athway conduction during ablation. This advantage prob-
bly offsets the fact that junctional acceleration cannot be
sed as a marker of the slow pathway location as it can
uring RFA.
Finally, the results of previous animal studies suggest that
ome advantages of cryo-therapy may be particularly impor-
ant for children. Cryo-ablation sites are histologically well
elineated, discrete, and show homogeneous dense fibrous
issue without viable myocardium interspersed (10). Cryo-
esions are smaller than RFA lesions (12), contributing to
he ability to safely create cryo-lesions even adjacent to the
is bundle, as was done for three of the patients in this
tudy. Presumably because the size of Koch’s triangle is
maller in children (27), the risk of causing AV node injury
ith any technique is higher in children (14–16).
tudy limitations. The small number of subjects in this
tudy limited the ability to reach statistical significance for
ome findings. The lack of a consistent protocol of when to
bandon cryo-ablation in this retrospective study clearly
llowed for user bias, making it difficult to draw conclusions
rom the failure rate, particularly for AVRT. Another
imitation was that the criteria for success were based upon
hose developed for RFA and may have been either too
tringent or too lenient for cryo-ablation. Clearly, future
rospective studies with pre-defined criteria for success and
ailure should be undertaken.
onclusions. Cryo-ablation can effectively be used to ab-
ate septal tachycardias in pediatric patients. Cryo-ablation
as used safely in this group of pediatric patients, even in
ery close proximity to the His bundle and during tachy-
ardia. In this series, cryo-therapy was more effective for
blation of AVNRT than for ablation of septal accessory
AVNRT AVRT p Value
22 8
14.2  3.6 11.1  2.9 0.05
59.2  21.9 38.6  11.1 0.05
11.8  10.1 2.3  1.3 0.05
9.9  9.9 1.6  1.2 0.05
3.6  2.0 1.1  0.4 0.01
13.5  10.9 2.8  1.3 0.05
1,370  837 388  138 0.01
21 (95.5) 5 (62.5) 0.05
1 (4.8) 2 (40.0) NS
ioventricular reciprocating tachycardia; CA  cryo-ablation;ents
3.6
21.2
9.4
9.1
2.0
10.3
830
.1)
.1)athways.
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